Thank you, Mr. Chairman.
When the CDR was set up and the decision-makers decided that it was an appropriate route to take, were there any drugs being approved that shouldn't have been approved? When this extra layer of review was put in, were there cases that sparked the decision? Was there a case where a provincial body was approving a drug prematurely? Was giving the best possible drug to those patients in need somehow inhibited? Are there any cases like these that merited the creation of this body?
I just want to know whether there were any actual errors that might have sparked this extra layer of review.